Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

18012.1 PFLS-LS

Project title

Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders
Short description (English)	Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders
Abstract (German)	This follow-up project aims at optimizing existing small molecule lead series previously designed as potent and selective inverse agonists of the ghrelin receptor. The ultimate goal is to obtain preclinical drug candidates for the development of an innovative parenteral therapy of obesity linked with type 2 diabetes or other metabolic syndromes.
Abstract (English)